Definitive Healthcare Corp

Insider sales by Jason Krantz and CEO Kevin Coop reveal a strategic trim amid a 57% YTD drop, hinting at portfolio hedging rather than panic in Definitive Healthcare.

CEO Kevin Coop’s March 1 sale of 175k shares—tax‑driven, not bearish—shows Definitive Healthcare’s execs still hold long‑term stakes amid a 76% YTD plunge.

Insider sale of Definitive Healthcare shares sparks investor concern. Discover why Krantz’s February 2026 trade could signal short‑term doubts and what to watch for in upcoming filings.

Discover how CFO Heller Casey’s recent RSU purchase signals confidence in Definitive Healthcare’s upside, balancing insider sales and long‑term growth.